Thyroid-stimulating hormone and risk of sudden cardiac death, total mortality and cardiovascular morbidity.

Ville L LangénTeemu J NiiranenPauli PuukkaArttu O LehtonenJussi A HernesniemiJouko SundvallVeikko SalomaaAntti M Jula

Published in: Clinical endocrinology (2017)

Thyroid function abnormalities could be linked with higher risks of total mortality and SCD. Large-scale randomized studies are needed for evidence-based recommendations regarding treatment of mild thyroid failure.

Keyphrases

cardiovascular events
risk factors
open label
double blind
randomized controlled trial
clinical trial
phase iii
coronary artery disease
combination therapy